ZPRÁVA O PRŮBĚHU KLINICKÉHO HODNOCENÍ HALF (16.6.2020 – 15.6.2021)

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Title in English	HALF CLINICAL TRIAL REPORT (16.6.2020 - 15.6.2021)
Authors	DEMLOVÁ Regina RYCHLÍČKOVÁ Jitka
Year of publication	2021
MU Faculty or unit	Faculty of Medicine
web	HALF
Description	Phase II prospective clinical study evaluating the efficacy and safety of tyrosine kinase inhibitors after previous two-stage dose reduction in patients with chronic myeloid leukemia in deep molecular remission.
Related projects:	Český národní uzel Evropské sítě infrastruktur klinického výzkumu (CZECRIN)